Inventor · disambiguated record
Dario Neri
Also filed as: NERI DARIO
40 granted patents·30 pending applications·441 citations·filing 1996–2023
98Inventor score
Files withPHILOGEN SPA25NERI DARIO11EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH7PHILOCHEM AG7MEDICAL RES COUNCIL4
Top patents by PatentIndex Score
70 records- 0194US9689879B2Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2016·Granted Jun 27, 2017·7 cites·7 claims
- 0293US6184012B1Isolation of enzymesMEDICAL RES COUNCIL·Filed 1997·Granted Feb 6, 2001·138 cites·17 claims
- 0392US9989536B2Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2017·Granted Jun 5, 2018·5 cites·7 claims
- 0492US8344177B2Albumin binding molecules and uses thereofPHILOCHEM AG·Filed 2007·Granted Jan 1, 2013·56 cites·36 claims
- 0590US10996226B2Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2018·Granted May 4, 2021·4 cites·4 claims
- 0689US8404814B2Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritisNERI DARIO·Filed 2007·Granted Mar 26, 2013·20 cites·12 claims
- 0787US7968685B2Antibodies against Tenascin-CPHILOGEN SPA·Filed 2005·Granted Jun 28, 2011·24 cites·14 claims
- 0886US9513296B2Specific and high affinity binding proteins comprising modified SH3 domains of Fyn kinaseEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2014·Granted Dec 6, 2016·6 cites·4 claims
- 0986US8481684B2Antigen associated with the neovasculature of tumour metastasesRYBAK JASCHA-NIKOLAI·Filed 2012·Granted Jul 9, 2013·11 cites·21 claims
- 1085US8263041B2Antigen associated with the neovasculature of tumour metastasesRYBAK JASCHA NIKOLAI·Filed 2008·Granted Sep 11, 2012·10 cites·11 claims
- 1185US6495673B1Method for isolating the DNA encoding an enzymeMEDICAL RES COUNCIL·Filed 2000·Granted Dec 17, 2002·12 cites·16 claims
- 1283US9446124B2Targeting of bone marrow neovasculaturePHILOGEN SPA·Filed 2014·Granted Sep 20, 2016·3 cites·7 claims
- 1382US8097254B2Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesisNERI DARIO·Filed 2004·Granted Jan 17, 2012·22 cites·17 claims
- 1481US9181347B2Antigen associated with the neovasculature of tumour metastasesPHILOGEN SPA·Filed 2013·Granted Nov 10, 2015·4 cites·20 claims
- 1581US8673824B2Encoded self-assembling chemical libraries (ESACHEL)NERI DARIO·Filed 2009·Granted Mar 18, 2014·3 cites·17 claims
- 1681US8642514B2Encoded self-assembling chemical libraries (ESACHEL)NERI DARIO·Filed 2009·Granted Feb 4, 2014·3 cites·22 claims
- 1781US8455625B2Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12NERI DARIO·Filed 2006·Granted Jun 4, 2013·12 cites·13 claims
- 1880US8679488B2Targeting of bone marrow neovasculatureKASPAR MANUELA·Filed 2010·Granted Mar 25, 2014·4 cites·9 claims
- 1979US9896503B2Antigen associated with the neovasculature of tumour metastasesPHILOGEN SPA·Filed 2015·Granted Feb 20, 2018·2 cites·21 claims
- 2079US8703143B2Antibodies of the ED-B domain of fibronectin, their construction and usesNERI DARIO·Filed 2007·Granted Apr 22, 2014·3 cites·23 claims
- 2177US10240147B2Production of encoded chemical librariesPHILOCHEM AG·Filed 2014·Granted Mar 26, 2019·3 cites·27 claims
- 2277US8623373B2Compositions and methods for treatment of angiogenesis in pathological lesionsZARDI LUCIANO·Filed 2001·Granted Jan 7, 2014·11 cites·15 claims
- 2374US8784824B2Compositions and methods for treatment of angiogenesis in pathological lesionsZARDI LUCIANO·Filed 2010·Granted Jul 22, 2014·3 cites·24 claims
- 2473US2023381324A1Small molecule drug conjugatesEIDGENOESSICHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2023·Application pending·0 cites
- 2572US7273924B1Antibodies to the ED-B domain of fibronectin, their construction and usesPHILOGEN SPA·Filed 1997·Granted Sep 25, 2007·24 cites·27 claims
- 2672US6316409B1Modified ligands of calcium-dependent binding proteinsMEDICAL RES COUNCIL·Filed 1997·Granted Nov 13, 2001·29 cites·19 claims
- 2771US9783843B2Encoded self-assembling chemical libraries (esachel)EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZÜRICH·Filed 2014·Granted Oct 10, 2017·1 cites·15 claims
- 2871US9096670B2Antibodies of the ED-B domain of fibronectin, their construction and usesPHILOGEN SPA·Filed 2013·Granted Aug 4, 2015·1 cites·18 claims
- 2970US10016511B2Small molecule drug conjugatesPHILOCHEM AG·Filed 2017·Granted Jul 10, 2018·1 cites·10 claims
- 3070US9884122B2Small molecule drug conjugatesPHILOCHEM AG·Filed 2016·Granted Feb 6, 2018·1 cites·6 claims
- 3168US8580267B2Immunocytokines for tumour therapy with chemotherapeutic agentsPEDRETTI MARTA·Filed 2009·Granted Nov 12, 2013·4 cites·12 claims
- 3268US2010215615A1Immunocytokines for cancer treatment in combination with chemotherapeutic agentsPHILOGEN S PA·Filed 2008·Application pending·0 cites
- 3366US2021308269A1Small Molecule Drug ConjugatesEIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2021·Application pending·0 cites
- 3466US2015010498A1Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic AgentsPHILOGEN SPA·Filed 2014·Application pending·0 cites
- 3564US10895019B2Encoded self-assembling chemical libraries (ESACHEL)EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH·Filed 2017·Granted Jan 19, 2021·0 cites·26 claims
- 3663US8796426B2Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpartNERI DARIO·Filed 2008·Granted Aug 5, 2014·0 cites·18 claims
- 3763US2025368738A1Anti-cd28 antibodiesPHILOGEN SPA·Filed 2023·Application pending·0 cites
- 3861US2025073239A1Combination of an immunocytokine comprising il-12 and a kinase inhibitorPHILOGEN SPA·Filed 2023·Application pending·0 cites
- 3961US2015030536A1Antigen associated with lung cancers and lymphomasPHILOGEN SPA·Filed 2014·Application pending·0 cites
- 4061US2004014090A1Encoded self-assembling chemical libraries (ESACHEL)Filed 2003·Application pending·0 cites
- 4161US2021369857A1Il2 and tnf mutant immunoconjugatesPHILOGEN SPA·Filed 2021·Application pending·0 cites
- 4259US9289470B2Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpartPHILOGEN SPA·Filed 2014·Granted Mar 22, 2016·0 cites·29 claims
- 4359US2010310454A1Combination of an anti-edb fibronectin antibody-il-2 fusion protein, and a molecule binding to b cells, b cell progenitors and /or their cancerous counterpartNERI DARIO·Filed 2008·Application pending·0 cites
- 4458US2013266511A1Novel antigen associated with the neovasculature of tumour metastasesPHILOGEN SPA·Filed 2013·Application pending·0 cites
- 4557US11103592B2IL2 and TNF mutant immunoconjugatesPHILOGEN SPA·Filed 2017·Granted Aug 31, 2021·0 cites·13 claims
- 4657US10858411B2IL22 immunoconjugatesPHILOGEN SPA·Filed 2019·Granted Dec 8, 2020·0 cites·14 claims
- 4757US2006154246A1Encoded self-assembling chemical libraries (esachel)NERI DARIO·Filed 2002·Application pending·0 cites
- 4857US2014377780A1Vascular Tumor MarkersPHILOGEN SPA·Filed 2014·Application pending·0 cites
- 4956US2010183506A1Antigen associated with lung cancers and lymphomasNERI DARIO·Filed 2008·Application pending·0 cites
- 5056US2024141043A1Bispecific antibody that binds to cd3 and a fluorophoreETH ZUERICH·Filed 2022·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dario Neri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →